News Celltrion Secures the EC’s Approval for Eydenzelt (Biosimilar, Eylea), Stoboclo & Osenvelt (Biosimilars, Prolia & Xgeva)ByRidhi RastogiFebruary 19, 20250Comments
News Gilead Reports US FDA’s NDA Acceptance of Lenacapavir for Pre-Exposure Prophylaxis (PreP) to Prevent HIV in Individuals at RiskByRidhi RastogiFebruary 19, 20250Comments
News Merck Receives the EC’s Approval for Welireg (Belzutifan) for Von Hippel-Lindau (VHL) Disease-Associated Tumors and Previously Treated Renal Cell CarcinomaByDipanshu DixitFebruary 19, 20250Comments
News Merus Receives the US FDA’s Breakthrough Therapy Designation for Petosemtamab to Treat 1L PD-L1+ Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)ByRidhi RastogiFebruary 19, 20250Comments
VIEWPOINTS Biogen at WMS 2024: Stephanie Fradette from Biogen in an Illuminating Dialogue Exchange with PharmaShotsBySaurabh ChaubeyFebruary 19, 20250Comments
News The US FDA Grants Breakthrough Therapy Designation to Innate Pharma’s Lacutamab for R/R Sézary SyndromeByRidhi RastogiFebruary 18, 20250Comments
News Exelixis Presents 5-year Follow-Up Data from P-III (CheckMate -9ER) of Cabometyx + Opdivo in Renal Cell Carcinoma Patients at ASCO GU 2025ByRidhi RastogiFebruary 18, 20250Comments
News Galderma’ Nemluvio Receives UK’s MHRA & Swissmedic Approval for Atopic Dermatitis and Prurigo NodularisByDipanshu DixitFebruary 18, 20250Comments
News Regeneron and Sanofi Report the US FDA’s sBLA Acceptance for Dupixent to Treat Bullous Pemphigoid (BP)ByRidhi RastogiFebruary 18, 20250Comments
